This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2-5 November 2021
Austria CenterVienna, Austria

2-5 November 2021
Austria Center,
Vienna, Austria

The Industry’s Leading Event in Europe to Accelerate Therapeutics to Market by Expediting R&D, Improving CMC Efficiency, and Building New Partnerships

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.

KEY AREAS OF FOCUS

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES Europe program features 6 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum. In addition, we have 1 partnering track that will keep you ahead of your competition, and work towards collaborations. 


Oligonucleotide Chemistry, Manufacturing & Controls
Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical
Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls
Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.


Peptide Discovery, Preclinical and Clinical
Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing
mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Macromolecular Drug Delivery
Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing


Partnering Strategies
Partnering Strategies

Keep abreast of the the latest success stories, learn how to tackle collaboration challenges, hear from biotech companies ready to commercialize, and take part in interactive discussions around relevant topics

TIDES US 2020 Virtual Attendee

"Overall, the virtual sessions were better than live sessions.  I could see who was attending, more questions were put forward in the virtual format vs approaching a microphone. The virtual format allowed viewing of past sessions making it easier to see everything and keep up with other critical work activities."

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. We have both physical or digital opportunities, so we can adjust to whatever you are looking for.